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ABSTRACT: A Bodipy-based energy transfer cassette with a
singlet oxygen reactive linker between the donor and acceptor
modules has an interesting emergent property, if the acceptor
module is also a photosensitizer. Singlet oxygen produced by
the photosensitizer reacts rapidly with the molecule itself to
liberate the energy donor, resulting in an enhanced
ﬂuorescence emission. The result is a self-reporting photo-
sensitizer providing an assessment of the singlet oxygen
production rate under the operational conditions.
Sensing analytes in solution is highly important both for theelucidation of the processes they are involved in and/or for
determining therapeutic/diagnostic approaches in diseases
where corresponding analytes are markers for various biological
anomalies.1,2 Apart from using analyte responsive molecules as
reporters, activatable therapeutic systems have been developed
as well, where the disease related parameter is used to initiate a
chemical/physical transformation in the therapeutic agent to
alter its activity. Activatable photosensitizers are one of such
therapeutics with a modulated activatability property.3−8
Exchange of ideas between the ﬁelds of therapeutic design
and molecular sensors is expected to yield great improvements
in personalized treatment and diagnostics. However, one of the
main problems not addressed so far in this overlap area, is the
inadequacy of measuring the eﬀect of any therapeutics directly.
Rather, the biological eﬀect is analyzed on a cellular level. For
the photosensitizers, the eﬀect of light, oxygen concentration,
cell penetration, and dark-toxicity determines the overall eﬀect
of the photosensitizer on the cell;9,10 hence, one has to be
cautious in speaking about the eﬃciency of singlet oxygen
production of a photosensitizer in a cell-culture experiment
since the observed outcome is a cumulative result, namely cell
death.
In this work, we address the issue of direct monitoring of
photosensitizer activity with the use of a singlet oxygen (1O2)
labile linker between the ﬂuorophore and a photosensitizer,
where the former is an electronic energy transfer (EET) donor
and the latter being an EET acceptor (Figure 1, BOD 2). The
rationale behind the design is such that EET from the
ﬂuorophore (FL, blue module in Figure 1) to the photo-
sensitizer (PS, green module on BOD 2) quenches the
emission of the FL to a great extent. PS and FL are attached to
one another with (Z)- 1,2-bis(alkylthio)ethene bridge due to
the fact that 1O2 susceptibility of this electron-rich oleﬁnic
linker is extensively exploited by us and others.11−16
According to the design, 1O2 generated by the PS upon
irradiation with red light is to act on the molecule itself and
cleave the linker, liberating the ﬂuorophore as a consequence.
Fluorescence of the free FL is reinstated which is the reporter
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Figure 1. Structure of the model compound (BOD 1), energy-transfer
cassette with self-reporting property (BOD 2), and the individual
energy-transfer modules.
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for the 1O2 generation activity of the PS. A model compound
with the same chemical architecture was also synthesized
(Figure 1, BOD 1), which lack halogens on the core BODIPY,
and as a consequence does not generate singlet oxygen
eﬃciently due to prohibited intersystem crossing (ISC).
Absorption and ﬂuorescence spectra of BOD 1 and BOD 2
and free donor and acceptor modules in acetonitrile are given
in Figure 2. Characteristic absorption peaks of 2,6-ethyl-1,3,5,7-
tetramethylBODIPYs at around 521 nm and distyryl-BODIPYs
at 655 nm are measured. Compounds have two distinct
emission peaks around 535 nm for donor emission, and 670
(BOD 1) or 681 nm (BOD 2) for acceptor emissions. Detailed
photophysical data for the energy-transfer cassettes and the
corresponding modules are given in Table 1. As a consequence
of EET, excitation with a 488 nm light, which is primarily
absorbed by the donor, results in a decreased ﬂuorescence from
the donor module compared to the emission of the free donor
BODIPY (Figure 3) with a decrease in quantum yield from
0.90 to 0.26 for BOD 1 and 0.34 for BOD 2 with a calculated
energy transfer of 71% and 61% for the compounds,
respectively. In BOD 1, emission at 670 nm is much more
intense due to the lack of a competing intersystem crossing
pathway in the acceptor module as it is in the case of
halogenated acceptor module of BOD 2. Energy transfer is also
calculated to be more pronounced in this model compound
(71% in BOD 1 compared to 61% in BOD 2). This may be due
to slightly larger overlap integral between the donor emission
peak and the acceptor absorption peak in this molecule. The
energy transfer processes in both compounds are further
demonstrated by the excitation spectra. When the emission of
the acceptor moiety is followed, excitation of the donor seems
to contribute to this ﬂuorescence whereas in the acceptor
module itself, there is no corresponding excitability in the
region of donor absorbance (Figures S1 and S2, Supporting
Information).
Showing that the energy transfer is taking place between the
modules in each compound (BOD 1 and BOD 2), the singlet
oxygen dependent recovery of the donor emission is analyzed
as an indication of PS activity. Eﬃcient 1O2 generation by the
halogenated BODIPYs upon irradiation is already well
studied.17−20 Here, each energy transfer systems are irradiated
with a LED lamp (660 nm, 2.5 mW/cm2 ﬂuence rate). Primary
red light absorbing species in the casettes are acceptor modules
Figure 2. Normalized electronic absorption (a) and normalized
emission (b) spectra of BOD 1, BOD 2, D, A1, and A2 in acetonitrile.
Each spectrum is normalized with respect to maximum absorption or
emission wavelength of each compound.
Table 1. Photophysical Characterization of BOD 1 and BOD
2 and Modules A1, A2, and Da
λabs (nm) ε (M
−1 cm−1) λF (nm) ϕF
b (λexc(nm))
BOD 1 521 61000 535 0.26
647 65000 670 0.58
BOD 2 521 59000 533 0.34
655 97000 681 0.22
A1 525 60000 670 0.53
A2 654 95000 680 0.39
D 520 59000 534 0.90
aAll values are measured in acetonitrile. bFor the emission band
peaking at 521 nm Rhodamine 6G (water, ϕF = 0.95, n = 1.333) and
for the emission band peaking at 670 and 680 nm Cresyl Violet
(MeOH, ϕF = 0.66, n = 1.329) were used as reference compounds for
quantum yield calculations. The refractive index of acetonitrile is taken
as 1.346.
Figure 3. Fluorescence spectra of BOD 1 (a), BOD 2 (b), and equally
absorbing donor module D in acetonitrile, excited at 488 nm.
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which are photosensitizer, or halogen-free ﬂuorophore in BOD
2 and BOD 1, respectively. Aliquots were taken in 10 min
intervals from the solutions of BOD 1 and BOD 2, and
emission spectra were acquired by excitation at 520 nm. The
solutions were kept under irradiation with red light for the
duration of the experiment. Singlet oxygen generated upon
excitation of the photosensitizer is expected to react readily
with the electron rich (Z)-1,2-bis(alkylthio)ethene linker and
subsequently release donor ﬂuorophore. This reaction can be
monitored with the increased ﬂuorescence of this module. As
shown in Figures 4 and 5, control compound BOD 1 which
lacks heavy atoms to facilitate intersystem crossing, display no
signiﬁcant change in emission spectra neither in dark, nor under
irradiation at 660 nm.
Just like BOD 1, BOD 2 shows no remarkable change in
emission intensity when kept in dark (Figure 5). However,
exposure to red light results in an almost 2-fold increase in
donor emission, which is attributed to singlet oxygen
dependent cleavage of the linker and subsequent disintegration
of the EET system. Quantum yield of the donor moiety in
BOD 2 restores back to free donor value within 80 min,
indicating complete cleavage of the 1O2 susceptible bond within
the given time scale. There is no signiﬁcant change in acceptor
emission in BOD 2 during the reaction. Hence, it is a useful
reference point and comparison of the donor emission at 532
nm (which increase throughout the reaction) to this almost
unchanged acceptor emission at 680 nm enables ratiometric
activity sensing of the singlet oxygen (Figure 5).
Absorption spectra of the compounds throughout the singlet
oxygen generation and reaction were also investigated, and no
signiﬁcant change is observed which can be interpreted as lack
of any chemical change in the core BODIPYs during the
reporting process, which would most likely yield distinct
spectral signatures (Figures S3 and S4, Supporting Informa-
tion).
In conclusion, we report a novel approach to monitor the
activity of a photodynamic sensitizer, using singlet oxygen
dependent release of a ﬂuorescent reporter module of an
energy transfer cassette, upon which ﬂuorescence is restored.
With a ratiometric comparison to the essentially unchanged
acceptor emission, singlet oxygen generation ability of the
photosensitizer can be assessed. The You group investigated16 a
similarly designed system for its drug release potential.
However, to the best of our knowledge, explicit reaction-
based modulation of EET21 toward singlet oxygen-dependent
ratiometric self-activity sensing of a photosensitizer has not
been reported before. In any case, the rate of increase in the
ﬂuorescence of the reporter module is a direct measure of the
rate of singlet oxygen generation under the conditions of the
study. This system can be further developed for direct analysis
of the activity of PDT agents in vivo. This will provide an
unprecedented capability for in vivo assessment of photo-
sensitizers for PDT in terms of singlet oxygen generation. This
in turn, may lead to more advanced photosensitizer based
therapeutics in the very near future.
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Figure 4. Change in ﬂuorescence spectra of BOD 1 (a) and BOD 2 in
dark and after irradiation with 660 nm light in acetonitrile (excited at
520 nm).
Figure 5. Normalized change in the ﬂuorescence intensity of donor
moiety in BOD 1 and BOD 2 (intensity at 532 nm) compared to
acceptor emission (intensity at 670 nm for BOD 1 and 680 nm for
BOD 2) before (0−20 min) and after irradiation (20−80 min) with
red light (excited at 520 nm).
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